Stroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a cross-sectional analysis

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author ABREU, Fernanda Gabriela de FMUSP-HC
GOULART, Alessandra Carvalho FMUSP-HC
BIRCK, Marina Gabriela FMUSP-HC
BENSENOR, Isabela Martins FMUSP-HC
dc.date.issued 2018
dc.identifier.citation SAO PAULO MEDICAL JOURNAL, v.136, n.5, p.398-406, 2018
dc.identifier.issn 1516-3180
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/29825
dc.description.abstract BACKGROUND: Secondary prevention of stroke is a very important goal for achieving continuous reduction in stroke mortality rates over the next decades. DESIGN AND SETTING: Cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), with data from Salvador, Vitoria, Belo Horizonte, Rio de Janeiro, Sao Paulo and Porto Alegre. METHODS: This descriptive analysis focused on secondary prevention of stroke among participants who self-reported a medical diagnosis of stroke at the baseline of ELSA-Brasil, and its association with sociodemographic characteristics. RESULTS: Overall, 197 participants (13%) reported a prior medical history of stroke. Participants with stroke were older and less educated and had lower mean monthly family income, compared with nonstroke participants. Among all stroke cases, 23.7% did not use any medication for secondary prevention of stroke. Use of secondary prevention was higher among men than among women (respectively, 59.6% versus 40.4%; P = 0.02 for aspirin; and 71.4% versus 28.6%; P = 0.04 for other antiplatelet drugs). Having private health insurance was associated with greater use of less cost-effective and more expensive medications (like angiotensinogen receptor blockers) and a tendency to use antiplatelet drugs other than aspirin, among participants reporting stroke, compared with others. Use of medication decreased as time passed after suffering a stroke. CONCLUSIONS: In this sample of individuals with better access to healthcare services, use of secondary prevention for stroke was low, which may suggest that the situation in the general population is worse. Sex was the most important sociodemographic variable associated with low use of secondary prevention.
dc.description.sponsorship · Brazilian Ministry of Health (Science and Technology Department)
· Brazilian Ministry of Science and Technology
· CNPq National Research Council [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]
· CAPES
· CNPq
dc.language.iso eng
dc.publisher ASSOCIACAO PAULISTA MEDICINA
dc.relation.ispartof Sao Paulo Medical Journal
dc.rights openAccess
dc.subject Cerebrovascular disorders; Stroke; Risk factor; Secondary prevention
dc.subject.other cardiovascular-disease prevention; global burden; hypertension; awareness; mortality; trends; availability; prevalence; management; adherence
dc.title Stroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a cross-sectional analysis
dc.type article
dc.rights.holder Copyright ASSOCIACAO PAULISTA MEDICINA
dc.description.group LIM/20
dc.description.group LIM/51
dc.identifier.doi 10.1590/1516-3180.2018.0129060818
dc.identifier.pmid 30570091
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author ABREU, Fernanda Gabriela de:FM:
hcfmusp.author GOULART, Alessandra Carvalho:HU:SCPACEX-62
hcfmusp.author BIRCK, Marina Gabriela:FM:
hcfmusp.author BENSENOR, Isabela Martins:FM:MCM
hcfmusp.origem.id WOS:000454008600003
hcfmusp.origem.id 2-s2.0-85058897935
hcfmusp.origem.id SCIELO:S1516-31802018000500398
hcfmusp.publisher.city SAO PAULO
hcfmusp.publisher.country BRAZIL
hcfmusp.relation.reference · AQUINO EML, 1992, REV SAUDE PUBL, V26, P195, DOI 10.1590/S0034-89101992000300011
· Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
· Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780
· Brasil. Ministerio da Saude Fundacao Oswaldo Cruz, 2005, PROGR FARM POP BRAS
· Brasil. Ministerio da Saude. Secretaria de Ciencia Tecnologia e Insumos Estrategicos. Departamento de Assistencia Farmaceutica e Insumos Estrategicos., 2015, REL NAC MED ESS RENA
· Cabral Norberto L, 2012, Am J Public Health, V102, pe90, DOI 10.2105/AJPH.2012.301024
· Carrington MJ, 2013, J HYPERTENS, V31, P1265, DOI 10.1097/HJH.0b013e3283606bc7
· Chor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382
· Dal Pizzol TD, 2010, CAD SAUDE PUBLICA, V26, P827, DOI 10.1590/S0102-311X2010000400024
· Fasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481
· Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106
· Fernandes TG, 2015, INT J STROKE, V10, P34, DOI 10.1111/ijs.12526
· Gamboa CM, 2017, J AM HEART ASS, V6
· Guerra AA, 2004, REV PANAM SALUD PUBL, V15, P168, DOI 10.1590/S1020-49892004000300005
· Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026
· Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024
· Kim Yeon-Yong, 2017, J Prev Med Public Health, V50, P294, DOI 10.3961/jpmph.17.024
· KOUTIS A D, 1991, Scandinavian Journal of Primary Health Care, V9, P297, DOI 10.3109/02813439109018536
· Lotufo PA, 2013, INT J STROKE, V8, P155, DOI 10.1111/j.1747-4949.2011.00757.x
· Lotufo PA, 2009, INT J STROKE, V4, P40, DOI 10.1111/j.1747-4949.2009.00240.x
· Lotufo Paulo Andrade, 2017, Rev. bras. epidemiol., V20, P129, DOI 10.1590/1980-5497201700050011
· Lotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510
· Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
· Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82
· Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255
· Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004
· Pinto CDS, 2010, REV SAUDE PUBL, V44, P611, DOI 10.1590/s0034-89102010005000021
· Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
· Stoverinck MJM, 1996, J FAM PRACTICE, V43, P567
· Vianna CA, 2012, CAD SAUDE PUBLICA, V28, P1122, DOI 10.1590/S0102-311X2012000600011
· Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
· Yamauti SM, 2015, CAD SAUDE PUBLICA, V31, P1648, DOI 10.1590/0102-311X00054814
· Bermudez JAZ, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.201605000SUPL2AP, 10.1590/s1518-8787.201605000supl2ap]
dc.description.index MEDLINE
hcfmusp.citation.scopus 0
hcfmusp.citation.wos 0


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics